Articles by Tyler Menichiello

1. How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction 6/30/2025

    Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.

2. Finding Compatibility In Love And CDMO Partnerships 6/26/2025

   Just like people, some sponsor-CDMO partnerships can be matches made in heaven. Others, not so much. See what experts have to say about finding the right CDMO and building a successful partnership together.

3. BIO2025 Recap: FDA Reducing Animal Testing, Governor Shapiro On Supporting Biopharma, Practical AI Use 6/24/2025

   Bioprocess Online chief editor Tyler Menichiello shares his three key takeaways from the 2025 BIO International Convention.

4. Analytics And Cross-Functional Communication: Keys To Purifying Complex Molecules 5/30/2025

   This summary features key takeaways from the Bioprocess Online Live event, "Challenges And Considerations For Purifying Multispecific Molecules."

5. How Modular Facility Design Can Accelerate GMP Facility Construction 5/20/2025

   Autolus Therapeutics' COO talks about the accelerated construction of the company's cell therapy manufacturing facility, The Nucleus.

6. A Facilities Expert Answers Audience Questions On Construction And Validation 5/5/2025

   Bioprocessing facility expert Herman Bozenhardt responds to some unanswered audience questions from a Pharmaceutical Online Live event on facility design and validation.

7. Experts' Advice On Facility Design And Construction 4/24/2025

   This is a review of the Pharmaceutical Online Live event “Facility Design And Validation Considerations For Drug Manufacturers," which featured industry experts Erich Bozenhardt and Herman Bozenhardt, as well as process architect Fred Grossfeld.

8. From BPI West: A Roundtable Discussion On Continuous Manufacturing 4/14/2025

   Process Development experts share their thoughts on continuous manufacturing at this year's BPI West, touching on its benefits and present barriers to adoption.

9. From BPI West: Key Challenges And Benefits Of Continuous Manufacturing 4/7/2025

   Continuous manufacturing was a hot topic of conversation at this year's BPI West. AstraZeneca's Ken Lee, Ph.D., weighs in during an exclusive interview with Bioprocess Online.

10. From BPI West: An Upstream Scientist's Advice On Target Glycosylation 4/1/2025

    Bioprocess Online spoke to an upstream scientist at Bristol Myers Squibb during this year's BPI West. Here's what he had to say.